Advertisement
Screener

UNICYCIVE THERAPEUTICS, INC. (UNCY) Deferred Tax Assets, Operating Loss Carryforwards, State and Local

UNICYCIVE THERAPEUTICS, INC. Deferred Tax Assets, Operating Loss Carryforwards, State and Local

UNICYCIVE THERAPEUTICS, INC. (UNCY) had Deferred Tax Assets, Operating Loss Carryforwards, State and Local of $46.80 million as of 2025-12-31, per its 10-K filed 2026-03-30.

Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components

us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal · last filed 2026-03-30

  • 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $46.80M.
  • 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $40.00M.
  • 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $11.60M.
  • 2021-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $9.50M.
Period endDeferred Tax Assets, Operating Loss Carryforwards, State and Local
2025-12-31$46.80M
10-K · filed 2026-03-30
2024-12-31$40.00M
10-K · filed 2025-03-31
2023-12-31$11.60M
10-K · filed 2024-03-28
2021-12-31$9.50M
10-K · filed 2022-03-31

Similar stocks

Stock NameCountryMarket CapPE Ratio
TuHURA Biosciences, Inc./NV (HURA)United States$0.134B-4.88
NRX Pharmaceuticals, Inc. (NRXP)United States$0.131B-6.31
Curanex Pharmaceuticals Inc (CURX)United States$0.138B
MEDICINOVA INC (MNOV)United States$0.130B-6.04
Atrium Therapeutics, Inc. (RNA)United States$0.140B
Korro Bio, Inc. (KRRO)United States$0.141B-1.81
IMMUNIC, INC. (IMUX)United States$0.127B-1.88
SPRUCE BIOSCIENCES, INC. (SPRB)United States$0.142B-2.89
INOVIO PHARMACEUTICALS, INC. (INO)United States$0.125B-1.35
Corbus Pharmaceuticals Holdings, Inc. (CRBP)United States$0.144B-1.72